Vinva Investment Management Ltd Reduces Holdings in The Clorox Company (NYSE:CLX)

Vinva Investment Management Ltd lowered its position in The Clorox Company (NYSE:CLX) by 53.8% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,675 shares of the company’s stock after selling 3,110 shares during the quarter. Vinva Investment Management Ltd’s holdings in Clorox were worth $437,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CLX. Prospera Private Wealth LLC bought a new position in Clorox in the 3rd quarter worth approximately $27,000. Innealta Capital LLC bought a new position in shares of Clorox in the second quarter worth $30,000. Trifecta Capital Advisors LLC grew its position in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares in the last quarter. Family Firm Inc. bought a new stake in shares of Clorox during the 2nd quarter valued at $31,000. Finally, Quarry LP lifted its holdings in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Up 0.0 %

Shares of Clorox stock opened at $167.17 on Friday. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.35. The company’s 50 day moving average price is $163.09 and its 200-day moving average price is $149.39. The stock has a market capitalization of $20.69 billion, a price-to-earnings ratio of 58.25, a P/E/G ratio of 3.09 and a beta of 0.41.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.49 earnings per share. Equities research analysts forecast that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 2.92%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is currently 170.03%.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.57% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Citigroup raised their price target on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, Evercore ISI cut their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.